Clinical opinion published in American Journal of Obstetrics and Gynecology

Dr. Charles Rardin contributes to the debate over the use of robotics for minimally invasive gynecologic surgery

2014-05-02

(Press-News.org) When a woman requires gynecologic surgery, she and her surgeon have several minimally invasive surgical options, including robotic surgery. In recent years, the use of robotic surgery has become more and more common. But questions have arisen about the potential overuse of robotic surgery and its advantages over traditional laparotomy for hysterectomy.

A clinical opinion by Charles Rardin, MD, a urogynecologist in the Division of Urogynecology and Reconstructive Surgery and director of the Robotic Surgery Program for Women at Women & Infants Hospital of Rhode Island, director of Minimally Invasive Surgery at Care New England, and associate professor of obstetrics and gynecology at The Warren Alpert Medical School of Brown University, entitled "The debate over robotics in benign gynecology," is published this month in the American Journal of Obstetrics & Gynecology.

"Robotic surgery certainly provides some advantages to some surgeons and has contributed to a decline in laparotomy (large incision) rates for hysterectomy," said Dr. Rardin. "But robotic surgery for benign gynecology needs to be considered as just one of several forms of minimally invasive surgery (MIS) that can be used to provide the best care to patients."

Dr. Rardin explained that specific features of the patient (ie obesity), the surgeon (ie his or her experience with laparoscopic surgery), or the case (ie the possibility of significant and technically challenging suturing, such as required for a fistula repair) may make the robotic approach preferable over laparoscopic or vaginal surgery.

"However, an institution that adopts a policy of promoting robotic surgery over other forms of minimally invasive surgery is at risk of becoming a 'robotic factory' and allowing volume and quality of vaginal or laparoscopic surgeries to dwindle," he said.

In his opinion piece, Dr. Rardin suggests that other organizations consider the approach taken at the Care New England hospitals (Kent, Memorial and Women & Infants), which focuses on the ability to provide the full spectrum of MIS procedures to each individual patient presenting for surgical care. He outlines how hospitals and physicians could promote a balanced approach to MIS by considering four issues: The development of rigorous and self-determined processes of quality management and feedback to surgical staff, as well as credentialing systems based on training, skills, peer support, and ongoing volume The development of case criteria, reserving the use of the robot to cases in which specifics of the patient, the surgeon or the case warrant it The ability to identify and address imbalances in surgical technique by monitoring the use and relative rates of MIS techniques for gynecology as well as the related patient outcomes data Providing structure and support for all forms of MIS, not just robotics, for trainees (residents and fellows) as well as those who have already completed formal training programs

This year, Women & Infants Hospital was designated a Center of Excellence in Minimally Invasive Gynecology (COEMIG) by the Surgical Review Corporation, an affiliate of the American Association of Gynecologic Laparoscopists (AAGL), for its commitment to offering women the most effective diagnostic and therapeutic techniques in minimally invasive surgery.

Covering the full spectrum of the specialty, American Journal of Obstetrics & Gynecology, "The Gray Journal," presents the latest diagnostic procedures, leading-edge research, and expert commentary in maternal-fetal medicine, reproductive endocrinology and infertility, gynecologic oncology, and urogynecology, as well as general obstetrics and gynecology.

INFORMATION: About Women & Infants Hospital Women & Infants Hospital of Rhode Island, a Care New England hospital, is one of the nation's leading specialty hospitals for women and newborns. A major teaching affiliate of The Warren Alpert Medical School of Brown University for obstetrics, gynecology and newborn pediatrics, as well as a number of specialized programs in women's medicine, Women & Infants is the eighth largest stand-alone obstetrical service in the country with nearly 8,400 deliveries per year. In 2009, Women & Infants opened the country's largest, single-family room neonatal intensive care unit.

New England's premier hospital for women and newborns, Women & Infants and Brown offer fellowship programs in gynecologic oncology, maternal-fetal medicine, urogynecology and reconstructive pelvic surgery, neonatal-perinatal medicine, pediatric and perinatal pathology, gynecologic pathology and cytopathology, and reproductive endocrinology and infertility. It is home to the nation's only mother-baby perinatal psychiatric partial hospital, as well as the nation's only fellowship program in obstetric medicine.

Women & Infants has been designated as a Breast Center of Excellence from the American College of Radiography; a Center of Excellence in Minimally Invasive Gynecology; a Center for In Vitro Maturation Excellence by SAGE In Vitro Fertilization; a Center of Biomedical Research Excellence by the National Institutes of Health; and a Neonatal Resource Services Center of Excellence. It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute's Gynecologic Oncology Group and the National Institutes of Health's Pelvic Floor Disorders Network.

ELSE PRESS RELEASES FROM THIS DATE:

Elevated liver enzyme levels linked to higher gestational diabetes risk

2014-05-02

OAKLAND, Calif., May 2, 2014 — Women with high levels of a common liver enzyme measured prior to pregnancy were twice as likely to subsequently develop gestational diabetes than those with the lowest levels, according to a Kaiser Permanente study published today in the journal Diabetes Care. The liver plays an important role in regulating glucose levels in the body. The liver enzyme, called gamma-glutamyl transferase (known as GGT), is a common marker of liver function and has also been associated with insulin resistance, which can be a precursor to gestational diabetes ...

MERS coronavirus can be transmitted from camel to man

2014-05-02

The so-called Middle East respiratory syndrome (MERS) coronavirus was first found in June 2012 in a patient from Saudi Arabia, who suffered from severe pneumonia. Since this time more than 300 persons have developed an infection, of whom about a third died. The fact that the Arabian camel is the origin of the infectious disease has been confirmed recently. The transmission pathways of the viruses, however, have not been clear until now. Viruses in humans and camels from one region are identical Virologists Norbert Nowotny and Jolanta Kolodziejek from the Institute ...

Approaching the island of stability: Observation of the superheavy element 117

2014-05-02

The periodic table of the elements is to get crowded towards its heaviest members. Evidence for the artificial creation of element 117 has recently been obtained at the GSI Helmholtz Centre for Heavy Ion Research, an accelerator laboratory located in Darm-stadt, Germany. The experiment was performed by an international team of chemists and physicists headed by Prof. Christoph Düllmann, who holds positions at GSI, Johannes Gutenberg University Mainz (JGU), and the Helmholtz Institute Mainz (HIM). The team included 72 scientists and engineers from 16 institutions in Australia, ...

Sofosbuvir: Indication of added benefit for specific patients

2014-05-02

The drug sofosbuvir has been available since January 2014 as a treatment for chronic hepatitis C infection. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) has now examined whether the new drug offers added benefit in comparison with the appropriate comparator therapy. The dossier submitted by the drug manufacturer provides indications of added benefit for non-pretreated patients infected with the virus of genotype 2. However, the extent ...

Out of shape? Your memory may suffer

2014-05-02

EAST LANSING, Mich. --- Here's another reason to drop that doughnut and hit the treadmill: A new study suggests aerobic fitness affects long-term memory. Michigan State University researchers tested 75 college students during a two-day period and found those who were less fit had a harder time retaining information. "The findings show that lower-fit individuals lose more memory across time," said Kimberly Fenn, study co-author and assistant professor of psychology. The study, which appears online in the research journal Cognitive, Affective & Behavioral Neuroscience, ...

A 30-year puzzle in breast cancer is solved

2014-05-02

In a new study published today in Cell Reports, scientists at the Fred Hutchinson Cancer Research Center demonstrate that mice lacking one copy of a gene called CTCF have abnormal DNA methylation and are markedly predisposed to cancer. CTCF is a very well-studied DNA binding protein that exerts a major influence on the architecture of the human genome, but had not been previously linked to cancer. Over 30 years ago, frequent loss of one copy of chromosome 16 was first reported in breast cancer but the gene or genes responsible remained to be identified. Dr. Gala Filippova, ...

Autoimmune diseases may succumb to new drug strategy

2014-05-02

New pharmaceuticals to fight autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis and psoriasis, may be identified more effectively by adding genome analysis to standard drug screening, according to a new study by a research team led by UC San Francisco and Harvard researchers, in collaboration with Tempero and GlaxoSmithKlein. In a study reported online April 17, 2014 in the journal Immunity, the scientists combined drug screening with state-of-the-art techniques for analyzing the genome, leading to three small molecules that improved symptoms in a mouse ...

Maternal deaths on the rise in the United States

2014-05-02

SEATTLE — The United States is among just eight countries in the world to experience an increase in maternal mortality since 2003 – joining Afghanistan and countries in Africa and Central America, according to a new study by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. The study, "Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013," published May 2 in The Lancet, ranked the United States number 60 in the list of 180 countries ...

Sharp decline in maternal and child deaths globally, new data show

2014-05-02

SEATTLE — Since the start of an international effort to address maternal and child mortality, millions of lives have been saved globally, two new studies by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington show. In 2000, the Millennium Development Goals (MDGs) were established by the United Nations to drive maternal and child deaths down by 2015. Child and maternal deaths had been falling in most countries since the 1980s, but the pace accelerated after the goals were set. If countries continue on this course, child deaths will fall ...

High quality 3-dimensional nanoporous graphene

2014-05-02

Sendai, Japan -- Three-dimentional (3D) nanoporous graphene with preserved 2D Dirac electronic characters was successfully synthesized by Dr. Yoshikazu Ito and Prof. Mingwei CHEN at Advanced Institute for Materials Research (AIMR), Tohoku University. The nanoporous graphene is constructed by a single layer graphene sheet that is continuously inter-connected to form a complex 3D network structure. This free-standing nanoporous graphene with an excellent crystallinity possesses high mobility, holding great promise for the applications in electronic devices. The nanoporous ...